Evaxion A (EVAX) Total Debt (2021 - 2025)
Evaxion A's (EVAX) quarterly Total Debt came in at $5.5 million in Q4 2025, down 32.2% YoY from $8.2 million in Q4 2024, and down 39.91% on a QoQ basis from $9.2 million in Q2 2025.
Evaxion A (EVAX) Total Debt (2021 - 2025) Analysis & Trends
Evaxion A (EVAX) has 5 years of Total Debt data on file, last reported at $5.5 million in Q4 2025.
- Quarterly Total Debt fell 32.2% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.5 million (down 32.2% YoY) and the FY2025 annual result came in at $5.5 million, down 32.2% from the prior year.
- Total Debt slipped to $5.5 million in Q4 2025, from $9.2 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $9.2 million in Q2 2025 to a low of $1.2 million in Q4 2021.
- A 5-year average of $6.7 million and a median of $8.0 million in 2022 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt soared 583.76% — and 2025, when it tumbled 32.2%.
- Tracing EVAX's Total Debt over 5 years: stood at $1.2 million in 2021, then soared by 583.76% to $8.0 million in 2022, then grew by 8.1% to $8.6 million in 2023, then decreased by 5.56% to $8.2 million in 2024, then plunged by 32.2% to $5.5 million in 2025.
- The last three Total Debt figures came in at $5.5 million (Q4 2025), $9.2 million (Q2 2025), and $8.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 9.34 Bn |
| 10 | Evaxion A | 27.94 Mn | 27.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.54 Mn |
| Jun 30, 2025 | 9.22 Mn |
| Dec 31, 2024 | 8.17 Mn |
| Jun 30, 2024 | 8.42 Mn |
| Dec 31, 2023 | 8.65 Mn |
| Jun 30, 2023 | 8.23 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Jun 30, 2022 | 7.46 Mn |
| Mar 31, 2022 | 7.84 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 1.26 Mn |